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Modeling the evolution of culture-adapted
human embryonic stem cells
Victor Olariu a, Neil J. Harrison b, Daniel Coca a,
Paul J. Gokhale b, Duncan Baker c, Steve Billings a,
Visakan Kadirkamanathan a, Peter W. Andrews b,⁎a Department of Automatic Control and Systems Engineering, University of Sheffield, Mappin Street, Sheffield S1 3JD, UK
b Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield S10 2TN, UK
c North Trent Clinical Cytogenetics Service, Sheffield Children’s Trust, Western Bank, Sheffield S10 2TH, UKReceived 5 August 2009; accepted 4 September 2009Abstract The long-term culture of human embryonic stem (ES) cells is inevitably subject to evolution, since any mutant that
arises with a growth advantage will be selectively amplified. However, the evolutionary influences of population size, mutation
rate, and selection pressure are frequently overlooked. We have constructed a Monte Carlo simulation model to predict how
changes in these factors can influence the appearance and spread of mutant ES cells, and verified its applicability by
comparison with in vitro data. This simulation provides an estimate for the expected rate of generation of culture-adapted ES
cells under different assumptions for the key parameters. In particular, it highlights the effect of population size, suggesting
that the maintenance of cells in small populations reduces the likelihood that abnormal cultures will develop.
© 2009 Elsevier B.V. All rights reserved.Introduction
It has become increasingly evident that human embryonic
stem (ES) cells acquire genetic changes on prolonged passage
in culture, and that these changes can affect their growth
and differentiation properties (Baker et al., 2007). In the
case of stem cells, which can undergo self-renewal,
differentiation, or death, it seems likely that they will be
subject to strong selection for any genetic variation that
tends to increase the probability of self-renewal. Evidence
that this is the case is suggested by the observation that the
most frequent karyotypic changes occurring in human ES
cells are nonrandom and the same as those that characterise
embryonal carcinoma (EC) cells, their malignant counter-
parts from testicular germ cell tumors (Baker et al., 2007;⁎ Corresponding author.
E-mail address: p.w.andrews@sheffield.ac.uk (P.W. Andrews).
1873-5061/$ – see front matter © 2009 Elsevier B.V. All rights reserved
doi:10.1016/j.scr.2009.09.001Draper et al., 2004). In both situations a mutation(s) that
increases the probability of self-renewal is likely to provide
the variant stem cells with a strong selective advantage.
The generation of culture-adapted, variant ES cells must
involve two potentially independent events—mutation and
selection. Understanding the cause of both will be crucial as
we develop techniques for expansion of ES cells for
applications pertinent to human medicine. In addition, the
gradual adaptation of ES cells to culture conditions provides
a unique model with which to explore the mechanisms that
may drive cancer progression in stem cell-based cancers.
Currently, we know little of the mechanisms that promote
mutation in the first instance, or the exact nature of the
selective advantage(s) that results. Various reports have
noted that karyotypic variants have not occurred in
particular laboratories or under particular culture condi-
tions, suggesting that some conditions either do not promote
mutation or do not favor selection of variants. However,.
51Modeling the evolution of culture-adapted human embryonic stem cellsthese studies are generally limited and do not take account
of the stochasticity of the mutation process, or the
interaction of population size, mutation rates, and selection
pressure. Indeed, the mutation rate that leads to chromo-
somal amplification through nondysjunction or translocation
in ES cells is not known. We have now investigated the
conditions that lead to the appearance of culture-adapted,
variant ES cells using Monte Carlo simulations, under
different assumptions of the mutation rate, population
size, and selection pressure.Figure 1 Results of a Monte Carlo simulation to estimate the
probabilities of mutant cell appearance in human ES cell
cultures. (A) Diagram of the Monte Carlo simulation for ES cell
culture, where pm, ps, and pd are the respective probabilities of
mutant, normal, or dead/differentiated cell generation on ES
cell division, and qm and qd are the respective probabilities of
generating a further mutant cell, or a dead/differentiated cell,
on mutant cell division. (B) The average time for mutant cell
appearance at the 0.2, 5, 50, and 90% levels across 50 simulation
runs, assuming N=106, pm=10
-6, and S=2. The earliest and
latest passages at which variant cells reached each detection
level are indicated.Results
The simulation model describes the growth and passaging of
cultures of ES cells under certain assumptions (schematised
in Fig. 1A). For simplicity, we assumed that the starting
population contains N genetically homogeneous ES cells and
that passaging involves harvesting at random and reseeding
N cells from the culture. Between passages, cells undergo
three divisions, with the potential for self-renewal, muta-
tion, or death/differentiation at each division. Further, we
assumed that all mutations are beneficial and that culture-
adapted, variant ES cells occur randomly with a frequency
pm, and that the mutant cells have a selective advantage, S,
relative to the wild-type parent cells. This selective
advantage is defined as the ratio between the probabilities
of variant and wild-type cells surviving as stem cells
postdivision. As such, it is a composite of the variations in
propensity for self-renewal, death, and/or differentiation in
the abnormal cells, and at this stage wemake no assumptions
as to the cause of S.
The possible values for these parameters that pertain to
human ES culture are poorly documented, in the case of N,
and virtually unknown in the case of pm and S. Although the
population size, N, should be readily measurable, it is rarely
recorded in the literature, but it is likely to vary significantly
from laboratory to laboratory depending on culture strategy.
From our own experience we would anticipate that selec-
tive, manual “cutting and pasting” techniques may involve
the transfer of as few as 103 to 104 cells per passage, whereas
mass culture techniques using enzymatic and nonselective
methods might transfer as many as 105 to 106 cells per
passage. Chromosomal rearrangements in diploid cells in
culture have been suggested to occur at rates of 10-3 to 10-5
per mitosis (Petersson and Mitelman, 1985; Holliday, 1989),
while mutations at the Aprt locus in mouse ES cells have
been reported to be as low as 10-9 (Cervantes et al., 2002).
So far there is little analysis of the rate of appearance of
adaptive changes in human ES cells, or the selective
advantages that these may offer variant cells. However,
the rate at which variant cells have been reported to take
over cultures (Table 1), often within a few passages (Baker et
al., 2007; Draper et al., 2004), suggests a strong relative
advantage for the adapted cells.
To test the model we initially assumed values for N, pm,
and S, with N=106, pm=10-6, and S=2.0. Based on these
values, we ran the simulation 50 times. In each run we
recorded the passage number at which the proportion of
abnormal cells reached 0.2, 5, 50, and 90% of all cells in the
population (Fig. 1B). The levels of 5 and 0.2% abnormal cells
were chosen as these are the levels of karyotypic abnormal-ity that can be readily detected by standard cytogenetic and
interphase FISH techniques, respectively. In these simula-
tions, cultures with variant cells were first detected at the
0.2% level, on average, after 14 passages, with complete
takeover by 42 passages. However there was a substantial
range: for example, 0.2% variants appeared as early as
8 passages or as late as 21 passages. Approximately 25
further passages were then required before the variant cells
accounted for whole population, but again with substantial
variation.
We next used the model to plot the probability of
appearance of abnormal cells at the 5% detection level
when N, pm, or S was changed (Fig. 2). As expected, the rate
of appearance of abnormal cultures decreased as N
decreased, since there were fewer cells subject to mutation,
with the time taken for abnormal cultures to appear rising
exponentially as the population size was reduced (Figs. 2A
and B). With values for N between 106 and 5×104, the
probability of cultures reaching a level of 5% abnormal cells
was high (N0.9) by passage 50. However, when N was
Table 1 Reports from our laboratory and the literature in which mutant cells have appeared, and the time taken for these
mutants to overtake the culture
Cell
line
Passage method Passage when
abnormality had
overtaken culture
Time taken for culture
takeover (passages, from




Shef5 Mechanical (unpublished, Sheffield) 46 ≤15 t(1;11)(p36;q13),
trp (17)(p11.2), + 20
H7 (s14) Enzymatic (Draper et al., 2004) 68 ≤36 + 17
H7 (s9) Enzymatic (Draper et al., 2004) 44 ≤9 + 17
H7 (s6) Enzymatic (Draper et al., 2004) 74 ≤53 der (6)(6;17q)
H14 (s9) Enzymatic (Draper et al., 2004) 44 ≤5 + 17
BG01 Mechanical (p42) and enzymatic
(p23) (Mitalipova et al., 2005)
65 ≤23 + 12, +17
HS237 Mechanical passage
(Inzunza et al., 2004)
61 ≤25 X, idic (Maitra et al.,
2005) (q21)
BG01 Mechanical and enzymatic passage
(Maitra et al., 2005)
41 ≤30 + 17q
H7 Enzymatic passage
(Maitra et al., 2005)
61 ≤22 Amplification of
chr 20 region
H9 Enzymatic passage
(Maitra et al., 2005)
≤45 Amplification of
chr 1 region
No intermediate information was available in these cases, so the data report only the last stage at which the cell line was 100%
karyotypically normal, to the point at which it was recorded as 100% karyotypically abnormal.
52 V. Olariu et al.reduced to 103, it took approximately 400 passages before
the probability of the proportion of abnormal cells reaching
5% was greater than 0.9. These results indicate that
passaging strategies involving the transfer of smaller
numbers of cells (e.g., by cut and paste) may appear to
give more stable cultures, without the emergence of
abnormal cells, than those involving the transfer of larger
numbers of cells (e.g., mass culture techniques using
enzymatic harvesting), purely because of the population
size.
To examine this further we simulated growing 104 cells,
either as a single large culture with 104 initial cells or as 10
cultures each having initially 103 cells. In each case we
carried out 500 independent runs of the simulation and
averaged the results. The rate of appearance of abnormal
cells was again lower when the same numbers of cells were
passaged as 10 small cultures compared to when they were
passaged as one single culture. Thus, with N=104, pm=106,
and S=2, a level of 5% abnormal cells was reached with a
probability of 0.5 after 58 passages when maintained as a
single culture, but only after 66 passages when maintained
as 10 smaller cultures (Fig. 3A). The discrepancy became
much more marked when the probability of reaching 50%
abnormal cells was assessed—P=0.5 at 70 passages for the
single large culture but at 235 passages for the 10 small
cultures (Fig. 3B). These results confirmed the impact of
population size on the stability of ES cultures, most likely
reflecting the relatively lower frequency of multiple
mutations occurring in smaller populations. This result was
also supported by a simplified analytical model (Supporting
Information).
When the values for pm and S were changed, the results
were as we expected, such that as pm increased, the
probability of abnormal cultures appearing increased, and
as S decreased, the probability of abnormal culturesdecreased. Indeed, when S approached 1.0 (i.e., no selective
advantage), the probability of abnormal cultures approached
0. However, we had little prior knowledge of the values of
these parameters, so sought to compare the simulation
model with the actual behavior of human ES cells in culture
in order to generate realistic estimates.
To approximate the selective advantage that accounts
for observed cases of culture adaptation, we first carried
out experiments in which established karyotypic variants of
human ES cell lines were mixed with their corresponding
parental diploid cells, and the rate at which the variant
cells took over the cultures was determined by cytogenetic
analysis at every other passage (Fig. 4A). These experi-
mental data were then compared with the results of the
numerical simulations in which pm was set as zero, since
the mixing experiment equates to a condition in which a
mutation had already occurred, and N was matched to the
number of cells passaged. By varying S in the simulation,
we found that a selective advantage between 2.0 and 2.8
permitted a close approximation of the simulations to the
rate of variant takeover in the mixed cultures tested.
Notably, the selective advantage was higher for later
passage, culture-adapted H7 cells compared to an earlier
passage of this adapted variant when each was tested by
mixing with early passage, diploid H7 cells. This is
consistent with adaptation being a dynamic process in
which the cells acquire additional adaptive features during
continued passage. We also noted a higher selective
advantage when the same variant cells (this time an H14
variant) were maintained in cultures passaged by trypsini-
sation rather than by collagenase treatment and scraping,
suggesting that adaptation in this case may increase single
cell survival.
Since these mixing experiments used variant ES cells that
had been maintained in culture for some time since their
Figure 2 The probabilities of mutant cell appearance at the 5% cytogenetic detection level when initial population size (N),
frequency of culture-adapted mutant generation (pm), and selective advantage (S) are varied. (A) The probability of mutant
population reaching 5% when N=103–106. (B) The passage number at which the probability of 5% mutant cell appearance is 0.5 when
N=103–106. (C) The probability of the mutant population reaching 5% when pm=10
-3–10-10. (D) The probability of the mutant
population reaching 5% when S=1–3. Simulations were run 50 times for each set of parameters.
53Modeling the evolution of culture-adapted human embryonic stem cellsoriginal appearance, we also wanted to assess the likely
selective advantage of variant cells as soon as possible after
their appearance. To do this we analysed data, mainly from
our own group, but also from the literature, where the rate
of takeover of newly identified karyotypic variant cells has
been recorded (Fig. 4B). In these cases, precise data on
population size were not available, but making an assump-
tion of N=105–106 (which equates to the range of culture
sizes that we use in our laboratory), it was evident that the
observed rates of takeover of recently adapted cells were
also generally consistent with a value of S approximating
2.0. As the mutants arising spontaneously have occurred in
different lines, some of which have also been cultured using
different strategies, the broad similarity in S is perhaps
surprising. This may be attributable to a conserved
mechanism of culture adaptation. Indeed, the correspon-
dence of the common amplification of chromosomes 12 and
17 in human ES cells in culture and EC cells in tumorssuggests that a predominant factor in selection is intrinsic
to the pluripotent nature of the cells and largely indepen-
dent of growth conditions. On the other hand, this frequent
value for S might reflect the lower threshold for selective
advantage any mutant must possess to be detected.
Assuming that S≈2, we used our data from the model
and the in vitro mixing experiments to estimate a likely
range for the advantageous mutation rate, pm, in human ES
cells, given initial population sizes ranging from 104 to 106.
The estimated values of pm that resulted in a good fit for
the simulation data were in the range of 10-5–10-7.
However, this is not the same as the overall mutation rate
of human ES cells per se, which may be higher, as
nonadvantageous mutations would also be expected to
arise, but would not be selected. Most of the culture-
adapted human ES cells so far reported seem to involve the
acquisition of extra copies of chromosome 12 or 17, most
likely by nondysjunction. If we assume that chromosomal
Figure 3 The effect of population size on culture adaptation.
(A) The probabilities of cultures reaching 5% abnormal cells in
simulations when 104 cells were maintained over successive
passages as one population of 104 cells, or 10 populations of 103
cells. (B) The probabilities of cultures reaching 50% abnormal
cells when 104 cells are maintained over successive passages as
one population of 104 cells, or 10 populations of 103 cells. The
results plotted are the summation of 500 simulation runs in both
cases.
Figure 4 The rate at which chromosomally variant, culture-
adapted human ES cells take over normal, diploid cells, in
normal cultures. (A) Experiments in which 99% diploid human ES
cells were deliberately mixed with 1% karyotypically abnormal
cells that had been previously derived and established from the
same original diploid cells (Materials and methods). For each
experiment the abnormal cell line used is indicated, as is the
passage at which it was taken and the culture strategy (T,
trypsin/versene; C, collagenase and scraping). The amount of
106 cells was seeded at each passage, and the proportion of
abnormal cells was assessed at every other passage by standard
G-banding cytogenetics techniques. For each experiment,
simulation data are fitted from which S was calculated, and
this is also shown on the plot. (B) Examples of cases in which the
successive stages of culture takeover by karyotypically abnormal
cells have been recorded. The data for sublines of human ES cell
54 V. Olariu et al.nondysjunction in human ES cells is random and that the
predominant advantageous variants involving chromosomes
12 and 17 represent about 10% of all variants arising in this
way (i.e., 2 out of 23 chromosomes), our results would be
consistent with an overall rate of nondysjunction in human
ES cells of 10-4–10-6. This is comparable with other estimates
of 10-3 to 10-5 per mitosis as the rate of general chro-
mosomal rearrangements in other diploid cells (Petersson
and Mitelman, 1985; Holliday, 1989).lines H1, H7, H14, and Shef2 were obtained in our laboratory;
the data for hES5 are taken from Buzzard et al. (Buzzard et al.,
2004). The indicated passage numbers (X axis) are those post
initial detection of the chromosomal variant. For comparison,
the simulated and experimental data for the mid-passage H7.s6
takeover shown in Fig. 3A are also repeated in this graph (N=106,
S=2, and pm=0).Discussion
The development of strategies to minimise the appearance
of genetically variant cultures of human ES cells remains a
high priority, particularly when it becomes necessary to
55Modeling the evolution of culture-adapted human embryonic stem cellsconsider scale up and expansion of cultures for particular
applications. Once the causes of genetic variation, particu-
larly chromosomal nondysjunction and rearrangement, are
elucidated, it is possible that techniques to reduce the
mutation rate, pm, may be found. For example, the rates of
chromosome nondysjunction might be influenced by stresses
caused by environmental factors such as oxygen tension or
nutrient supply. However, it is unlikely that mutation can be
completely prevented. The selection pressures might also be
influenced by suboptimal growth conditions, and it is telling
that a simple calculation based on the cell cycle time of
human ES cells (less than 24 h (Becker et al., 2006)) and
common passaging strategies (e.g., splitting cultures 1:2 or
1:3 every 4 or 5 days) suggests that in common laboratory
situations as many as 90% of the potential yield of cells in a
stock culture of human ES cells must be lost between
passages. This implies the potential for strong selection
pressures in normal ES cell stock cultures, and that these
might be reduced by improving culture techniques. On the
other hand, if the nature of the selective advantage of the
several common changes involving chromosomes 12 and 17 is
intrinsic to pluripotent stem cells, as suggested by their
occurrence both in ES cells in vitro and in EC cells in vivo, the
scope for reducing selection pressure, at least for some
karyotypic changes, by altering growth conditions may also
be limited.
The remaining parameter is population size. Our present
results indicate that this is an influential factor that must be
considered, both in analysing the results of experiments that
seek to address the causes of adaptation, and in developing
methods to minimise the appearance of adapted cultures
during scale up. Although various authors have suggested
that different culture strategies reduce the tendency for
culture adaptation, they have generally failed to take
account of the effects of population size. It is possible that
small populations, or the stochasticity of the mutation and
adaptation process, could explain many examples of pro-
longed maintenance of diploid cultures. Further, our results
highlight the practical issue that in maintaining human ES
cell cultures, there are real advantages if the cultures are
maintained in independent small cultures rather than in
single large cultures.
Our model described here necessarily involved various
simplifying assumptions. For example, we assumed that the
cells transferred at each passage are randomly selected
from the culture. While this may be true when cells are
dissociated by trypsinisation, it is probably not entirely
true in the case when clumps of cells are transferred. Thus
neighboring cells in a clump are more likely to be related
to one another than to more distant cells. Indeed, operator
selection is likely to be an issue in cutting and pasting
strategies for maintaining cultures. There is also a myriad
of possible culture strategies in terms of split ratios and
the numbers of cell divisions between passages, which will
clearly affect the precise rates at which variant cells
appear. Further, we did not distinguish the possible
causative factors (e.g., survival potential or propensity
for differentiation) that contribute to the selective
advantage of variant cells. All could be built into more
sophisticated future models. Nevertheless, the present
model and results do highlight the need to consider
carefully the key parameters of population size, mutationrate, and selection pressure, as well as the stochasticity of
the process, in any analysis of factors that affect the rates
of ES cell culture adaptation.Materials and methods
Simulation study
We considered ES cell populations consisting of two types of
undifferentiated cells, nonmutant and mutant. Both are
assumed to be capable of dividing to yield undifferentiated
progeny, or to differentiate or die. For the purposes of this
simulation we have assumed that the differentiated cells do
not divide. Let NS(t,z) and NM(t,z) be the number of
nonmutant and mutant cells, respectively, after t passages
and z division cycles (over the last passage). There are three
division cycles per passage so z=0, 1, 2, 3. The number of ES
cells passaged, N(t,0)=Ns(t,0)+Nm(t,0), is assumed constant
for a complete simulation (t=0,1,…) and N=N(0,0)=Ns(0,0)
represents the initial number of nonmutant ES cells used to
start the colony at t=0. Assuming that mutations are
random, normal cells are allowed to divide into normal,
mutant, or dead/differentiated cells with corresponding
probabilities ps,pm,pd. Mutants can divide into mutants or
differentiated/dead cells with respective probabilities qm,
qd with no possibility for backmutation. The process is
illustrated as a diagram (Fig. 1A). A similar model but with
bidirectional mutation has been applied to B cells of the
immune system by Jolly et al. (Jolly et al., 2007).
For each division cycle z we have 2NS(t,z–1) independent
trials for nonmutant cells with three elementary random
events (nonmutant, mutant, and differentiated/dead) and
2 Nm(t,z–1) independent trials for mutant stem cells with
two elementary events (mutant or differentiated/dead). In
the first case the numbers of nonmutant, mutant, and
differentiated cells are determined by random sampling
from a trinomial distribution with parameters ps, pm, pd. In
the second case the outcome is a binomial random variable
with parameters qm and qd.
In the simulations, mutations are assumed to be
advantageous. To indicate selection between the two
types of cells qdbpd. The selective advantage of mutant
cells over nonmutant cells is denoted by S=qd/pd. In our
model, cells can mutate or differentiate/die only during
cell divisions that take at fixed time intervals, simulta-
neously for all cells in a colony. Passaging is implemented
as a simple random sampling without replacement process,
in which a sample of N(t,0) cells is drawn from the
population of N(t–1,3) cells (pure and mutant ES cells)
resulting after three divisions.
The model is a variation of the classical model devised by
Luria and Delbruck (Luria and Delbruck, 1943) to study
mutations in bacterial populations which assumed determin-
istic exponential growth (no death). This model was studied
and developed further by many authors including Lea and
Coulson (Lea and Coulson, 1949), Armitage (Armitage, 1952),
Crump and Hoel (Crump and Hoel, 1974), and Ma et al.
(Ma et al., 1992). A more complete stochastic modeling
framework for the mutation–birth–death process was intro-
duced by Tan (Tan, 1982), who derived the probability dis-
tribution of the number of mutants for any fixed time interval.
56 V. Olariu et al.Human ES cell culture and passage strategy
The H1, H7, and H14 human ES cells maintained in the Centre
for Stem Cell Biology (CSCB) were obtained from Dr. James
Thomson, University of Wisconsin, and were cultured as
previously described (Amit et al., 2000; Draper et al., 2004).
The Shef lines were derived on mouse embryo fibroblast
feeders using standard techniques, and cultured as previ-
ously described (Baker et al., 2007). Sublines of H7 (s6 and
s14) and H14 (s1 and s9) were isolated in the CSCB, 15
passages subsequent to original line derivation. H7.s14 was
used at passage 40, and maintained a normal karyotype (46,
XX) throughout the study. H7.s6 was used at two passage
levels, with mid passage H7.s6 taken at passage 120 (47,XX,
+1, der(6)t(6;17)(q27;q1)) and late passage H7.s6 taken at
passage 230 (48, XXX, +1 der(6)t(6;17)(q27;q1)). H14.s9 was
used at passage 35 (46, XY) and the variant subline H14.s1
used at passage 130 (48,XY +12, +der(17) del(17)(p12p13.3)
hsr(17)(p11.2)). For the karyotypically normal/abnormal cell
mixing experiments, parallel flasks were maintained
throughout the study. Here, cells in one flask were
dissociated with trypsin/versene and the total cell number
was determined, from which the appropriate passage ratio
for the second flask was calculated such that N=106. The
second flask was then passaged either by scraping following
brief collagenase treatment (Amit et al., 2000) or by
dissociation through brief trypsin/versene treatment.
Cytogenetic analyses
The human ES lines maintained at the University of Sheffield
are routinely karyotyped every 5–6 passages using standard
G-banding techniques (Baker et al., 2007). During the human
ES cell mixing experiments, cultures were taken at every
other passage and analysed by fluorescent in situ hybridisa-
tion (FISH) to determine the percentage of abnormal cells.
Cells were fixed on glass microscope slides using methanol:
acetic acid (3:1) and analysed using the isochromosome 17q
probe (Kreatech), specific for p53 at 17p13 and MPO at
17q23. All hybridisations were performed following the
manufacturers instructions. Slides were analysed on a
fluorescent microscope with appropriate filters and software
(Cytovision 3.6; Applied Imaging Corporation, San Jose, CA).
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